The main findings of the present study are that: i) pre-treatment (i.e., baseline) blood glucose level was significantly and positively correlated with pre-treatment PHDD; ii) pre-treatment blood glucose level was positively correlated with PHDD during treatment, and that association reached statistical significance for weeks 4 and 8 of treatment; iii) pre-treatment glucose levels did not correlate significantly with alcohol craving, as measured by the OCDS.
